SMAD4 and neoplasm: Upon Smad4 reactivation, liver metastases expressing shRen and shRunx1 continued to show a reduction in tumor burden consistent with SMAD4-mediated tumor suppression, whereas those expressing shKlf4 now exhibited a threefold increase in metastasis burden, akin to the behavior of lung metastases (Fig. 8a,b).